凯发天生赢家一触即发首页

You are here： Home  >> Technical services  >> Scientific research services

Scientific research services


I. Service content:

 

II. Core benefits:

•  The onlystable transfection processretroviralEnjoy discounts when repurchasingretroviral vectors
•  If commercialization of the resultsis required later,retroviral vectorsand cell products can beseamlessly integrated intoGMP-levelproduction servicesultra-low cost ; •  Retroviral vectorscan carrylarge target fragmentsup to 7kb ; •  ForNK cellsthat are difficult to infect withlentivirusesthe transduction efficiencyusingretroviralover 50%,with a viability rate of over 95%; •  A professional technical team providesfull-process technical supportto ensure the smooth progress of the project.



III. Case Study
 


IV. Service Cases

Shenzhen Cell Valley has launched a comprehensive collaboration with Academician Tian Zhigang's team at Enkasai Pharmaceuticals, focusing on CAR-NK drug development projects and assisting in the optimization, development, and production of retroviral vectors to accelerate the development of therapeutic drugs.

Shenzhen Cell Valley has launched a comprehensive collaboration with Academician Yan Xiyun's team at the Institute of Biophysics, Chinese Academy of Sciences, on retroviral vector preparation, CAR-T cell preparation , and related technology transfer. This collaboration aims to promote the industrialization of high-quality research results, help good products move from research institutes to the market, and create a new business model for CAR-T cell products using domestically produced retroviral vectors.


About Us
Scan to follow our latest newsScan to follow our latest news
Contact Us
400-800-1266

Working hours: Monday to Friday, 9:00-18:00

Contact：Ms. Lai

Email：laijiaqi@aicaocy.com

Address：No. 1, Rongtian Road, Jinsha Community, Kengzi Street, Pingshan District, Shenzhen, China (Hepure Biomedical Ecological Park)

Bottom Navigation
Shenzhen Cell Valley Biopharmaceutical Co., Ltd.​​ is a comprehensive one-stop outsourcing service provider in China focused on the cell and gene therapy industry. It is also one of the first CRO/CDMO companies in the country to possess GMP industrial production capabilities for clinical-grade retroviral vectors . The company is a major public technical service platform construction project for CRO/CDMO in Shenzhen and is included among the city's latest announced "20+8" strategic emerging industry projects.Shenzhen Cell Valley has the capability for standardized and industrialized production of GMP-grade cell products such as CAR-T cells. Its primary production lines include those for various cell products like CAR-T, CAR-NK, CAR-M, γδT, TIL, and TCR-T. Additionally, the company operates production lines for various viral vectors, including RVV, LVV, non-viral vectors, and AAV, as well as for cellular raw materials used in producing therapeutics such as exosomes, genetically engineered antibodies, cytokines, oncolytic viruses, and vaccines.
 Copyright 粤ICP备2024168379号 互联网药品信息服务资格证书：(粤)-非经营性-2022-0426  Technical Support：YouDian Software